+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS



Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS



Journal of Pharmaceutical and Biomedical Analysis 102: 353-365



The present study reports the degradation behavior of a new antidepressant drug, vilazodone, under various stress conditions as per International Conference on Harmonization guidelines (ICH, Q1A(R2). The investigation involved monitoring decomposition of the drug under hydrolytic (acidic, basic and neutral), oxidative, photolytic and thermal stress conditions and identifying degradation products. A rapid, precise, accurate and robust ultra high performance liquid chromatography (UPLC) method has been developed on a Waters CSH Phenyl-Hexyl column (100 mm × 2.1 mm, 1.7 μm) using gradient elution of 10mM ammonium acetate buffer (pH 5.0) and acetonitrile as mobile phase. The drug was found to be degraded in hydrolytic (acidic and basic) and oxidative conditions, whereas it was stable under neutral hydrolytic, photolytic and thermal stress conditions. The method was extended to quadrupole time-of-flight mass spectrometry (QTOF-MS) for the structural characterization of degradation products. It has been observed that isomeric N-oxide degradation products were formed under oxidative stress condition. The exact location of N-oxidation in the drug was investigated using atmospheric pressure chemical ionization (APCI) due to the formation of characteristic fragment ions. These fragment ions resulted from Meisenheimer rearrangement owing to thermal energy activation at the vaporizer of APCI source. All degradation products were comprehensively characterized by UPLC-ESI-MS/MS and UPLC-APCI-MS experiments. The most probable mechanisms for the formation of degradation products have also been proposed. The method was validated in terms of specificity, linearity, accuracy, precision, and robustness as per ICH guidelines.

(PDF emailed within 0-6 h: $19.90)

Accession: 058039602

Download citation: RISBibTeXText

PMID: 25459935

DOI: 10.1016/j.jpba.2014.09.033


Related references

A new method to identify hydrolytic degradants in drug substances with UPLC-MS using ¹⁸O-labelled water. Journal of Pharmaceutical and Biomedical Analysis 122: 9-15, 2016

The spider Paracoelotes birulai: detection and structure elucidation of new acylpolyamines by on-line coupled HPLC-APCI-MS and HPLC-APCI-MS/MS. Helvetica Chimica Acta 83(12): 3295-3305, 2000

The urinary metabolic profile of metyrapone in the rat. Identification of two novel isomeric metyrapol N-oxide metabolites. Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(1): 64-69, 1992

Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures. Journal of Chromatography. A 1058(1-2): 61-66, 2004

Characterisation of castor oil by on-line and off-line non-aqueous reverse-phase high-performance liquid chromatography-mass spectrometry (APCI and UV/MALDI). Phytochemical Analysis 14(6): 337-346, 2003

Separation and analysis of trace degradants in a pharmaceutical formulation using on-line capillary isotachophoresis-NMR. Analytical Chemistry 79(22): 8446-8453, 2007

Identification of low-level degradants from low dose tablets. Journal of Pharmaceutical and Biomedical Analysis 36(2): 265-275, 2004

Identification of volatile degradants in formulations containing sesame oil using SPME/GC/MS. Journal of Pharmaceutical and Biomedical Analysis 44(2): 450-455, 2007

Synthesis and identification of two potential oxidation degradants of oxymetazoline. Rapid Communications in Mass Spectrometry 18(14): 1645-1654, 2004

Forced degradation of fentanyl: identification and analysis of impurities and degradants. Journal of Pharmaceutical and Biomedical Analysis 53(3): 325-334, 2010

The identification of the UV degradants of melatonin and their ability to scavenge free radicals. Journal of Pineal Research 32(4): 257-261, 2002

FTIR assay method for UV inactive drug carisoprodol and identification of degradants by RP-HPLC and ESI-MS. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 1029-1030: 16-21, 2016

Degradation of a lyophilized formulation of BMS-204352: identification of degradants and role of elastomeric closures. Pharmaceutical Development and Technology 10(2): 227-232, 2005